Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 101

1.

Ethical and legal duty of anesthesiologists regarding Jehovah's Witness patient: care protocol.

Takaschima AK, Sakae TM, Takaschima AK, Takaschima RD, Lima BJ, Benedetti RH.

Braz J Anesthesiol. 2016 Nov - Dec;66(6):637-641. doi: 10.1016/j.bjane.2015.03.012.

2.

[Ethical and legal duty of anesthesiologists regarding Jehovah's Witness patient: care protocol].

Takaschima AK, Sakae TM, Takaschima AK, Takaschima RD, de Lima BJ, Benedetti RH.

Rev Bras Anestesiol. 2016 Nov - Dec;66(6):637-641. doi: 10.1016/j.bjan.2015.03.008. Portuguese.

3.

Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism.

Imberti D, Pomero F, Benedetti R, Fenoglio L.

Intern Emerg Med. 2016 Oct;11(7):895-900. doi: 10.1007/s11739-016-1521-8.

PMID:
27550399
4.

The management of patients with venous thromboembolism in Italy: insights from the PREFER in VTE registry.

Guercini F, Mommi V, Camporese G, Tonello C, Imberti D, Benedetti R, De Bartolomeo G, Di Lecce L, Romeo F, Agnelli G.

Intern Emerg Med. 2016 Dec;11(8):1095-1102.

PMID:
27448310
5.

c-Myc modulation & acetylation is a key HDAC inhibitor target in cancer.

Angela N, Carafa V, Conte M, Tambaro FP, Abbondanza C, Martens JH, Nees M, Benedetti R, Pallavicini I, Minucci S, Garcia-Manero G, Iovino F, Lania G, Ingenito C, Belsito Petrizzi V, Stunnenberg HG, Altucci L.

Clin Cancer Res. 2016 Jun 29. pii: clincanres.2388.2015. [Epub ahead of print]

PMID:
27358484
6.

An rK28-Based Immunoenzymatic Assay for the Diagnosis of Canine Visceral Leishmaniasis in Latin America.

Lauricella MA, Maidana CG, Frias VF, Romagosa CM, Negri V, Benedetti R, Sinagra AJ, Luna C, Tartaglino L, Laucella S, Reed SG, Riarte AR.

Am J Trop Med Hyg. 2016 Jul 6;95(1):92-8. doi: 10.4269/ajtmh.13-0768.

PMID:
27162270
7.

OC-01 - Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study.

Dentali F, Pegoraro S, Barco S, di Minno MN, Mastroiacovo D, Pomero F, Lodigiani C, Bagna F, Sartori M, Barillari G, Mumoli N, Napolitano M, Passamonti S, Benedetti R, Ageno W, Nisio MD.

Thromb Res. 2016 Apr;140 Suppl 1:S168. doi: 10.1016/S0049-3848(16)30118-9.

PMID:
27161673
8.

Primary prophylaxis of VTE in cancer outpatients.

Imberti D, Benedetti R.

Thromb Res. 2016 Apr;140 Suppl 1:S103-8. doi: 10.1016/S0049-3848(16)30108-6. Review.

PMID:
27067962
9.

Epigenetic-based therapy: From single- to multi-target approaches.

Benedetti R, Conte M, Iside C, Altucci L.

Int J Biochem Cell Biol. 2015 Dec;69:121-31. doi: 10.1016/j.biocel.2015.10.016. Review.

PMID:
26494003
10.

Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study.

Palareti G, Legnani C, Cosmi B, Antonucci E, Erba N, Poli D, Testa S, Tosetto A; DULCIS (D-dimer-ULtrasonography in Combination Italian Study) Investigators (See Appendix).; DULCIS (D-dimer-ULtrasonography in Combination Italian Study) Investigators..

Int J Lab Hematol. 2016 Feb;38(1):42-9. doi: 10.1111/ijlh.12426.

PMID:
26362346
11.

A Novel Modulator of Kv3 Potassium Channels Regulates the Firing of Parvalbumin-Positive Cortical Interneurons.

Rosato-Siri MD, Zambello E, Mutinelli C, Garbati N, Benedetti R, Aldegheri L, Graziani F, Virginio C, Alvaro G, Large CH.

J Pharmacol Exp Ther. 2015 Sep;354(3):251-60. doi: 10.1124/jpet.115.225748.

12.

Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.

Nebbioso A, Benedetti R, Conte M, Iside C, Altucci L.

Expert Opin Ther Targets. 2015;19(9):1187-202. doi: 10.1517/14728222.2015.1051728. Review.

PMID:
26028314
13.

Venous Thromboembolism in Patients Undergoing Shoulder Arthroscopy: Findings From the RECOS Registry.

Imberti D, Dentali F, Ivaldo N, Murena L, Paladini P, Castagna A, Barillari G, Guerra E, Tonello C, Castoldi F, Lazzaro F, Benedetti R, Camporese G, Porcellini G; RECOS Investigators..

Clin Appl Thromb Hemost. 2015 Jul;21(5):486-8. doi: 10.1177/1076029614567311. No abstract available.

PMID:
25616489
14.

HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape.

Conte M, Dell'Aversana C, Benedetti R, Petraglia F, Carissimo A, Petrizzi VB, D'Arco AM, Abbondanza C, Nebbioso A, Altucci L.

Oncotarget. 2015 Jan 20;6(2):886-901.

15.

Analysis of chromatin-nuclear receptor interactions by laser-chromatin immunoprecipitation.

Benedetti R, Conte M, Carafa V, Della Ventura B, Altucci C, Velotta R, Stunnenberg HG, Altucci L, Nebbioso A.

Methods Mol Biol. 2014;1204:25-34. doi: 10.1007/978-1-4939-1346-6_3.

PMID:
25182758
16.

Apixaban versus enoxaparin in elective major orthopedic surgery: a clinical review.

Maniscalco P, Caforio M, Imberti D, Porcellini G, Benedetti R.

Clin Appl Thromb Hemost. 2015 Mar;21(2):115-9. doi: 10.1177/1076029614546328. Review.

PMID:
25125051
17.

D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study.

Palareti G, Cosmi B, Legnani C, Antonucci E, De Micheli V, Ghirarduzzi A, Poli D, Testa S, Tosetto A, Pengo V, Prandoni P; DULCIS (D-dimer and ULtrasonography in Combination Italian Study) Investigators..

Blood. 2014 Jul 10;124(2):196-203. doi: 10.1182/blood-2014-01-548065.

18.

Quinoline-based p300 histone acetyltransferase inhibitors with pro-apoptotic activity in human leukemia U937 cells.

Lenoci A, Tomassi S, Conte M, Benedetti R, Rodriguez V, Carradori S, Secci D, Castellano S, Sbardella G, Filetici P, Novellino E, Altucci L, Rotili D, Mai A.

ChemMedChem. 2014 Mar;9(3):542-8. doi: 10.1002/cmdc.201300536.

PMID:
24504685
19.

Targeting Histone Deacetylases in Diseases: Where Are We?

Benedetti R, Conte M, Altucci L.

Antioxid Redox Signal. 2015 Jul 1;23(1):99-126. doi: 10.1089/ars.2013.5776. Review.

20.

Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities.

Rotili D, Tomassi S, Conte M, Benedetti R, Tortorici M, Ciossani G, Valente S, Marrocco B, Labella D, Novellino E, Mattevi A, Altucci L, Tumber A, Yapp C, King ON, Hopkinson RJ, Kawamura A, Schofield CJ, Mai A.

J Med Chem. 2014 Jan 9;57(1):42-55. doi: 10.1021/jm4012802.

PMID:
24325601
Items per page

Supplemental Content

Loading ...
Support Center